This is especially notable because lysosomal dysfunction is an important contributor to Huntington’s disease24 and mH2A1 has been identified as a biomarker that tracks Huntington’s disease severity in human patients and mouse models11. The gene discussed is MACROH2A1; the disease is juvenile Huntington disease.